As of 1:47pm ET
| +0.03 / +1.23%|
The 2 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 2.25, with a high estimate of 2.50 and a low estimate of 2.00. The median estimate represents a -8.54% decrease from the last price of 2.46.
The current consensus among 3 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.